Postcards from the Living
UCSF alum Jenny Qi, PhD ’17, shares a poem from her first book, Focal Point
University of California San Francisco
Give to UCSFUCSF alum Jenny Qi, PhD ’17, shares a poem from her first book, Focal Point
Keith Yamamoto, PhD, UCSF’s director of precision medicine, explains how a new tool – a knowledge network – will transform health care.
Americans save billions of dollars using lower-cost generics instead of brand-name drugs. Are they as effective?
UCSF neurologist Gil Rabinovici, MD, explains the controversy and shares why he thinks Alzheimer’s care is entering a new era “regardless of whether aducanumab proves to be a blockbuster or a bust.”
Monica Gandhi, MD, MPH, an infectious disease expert and professor of medicine, has been an ardent voice for science during the coronavirus pandemic.
UCSF’s David Julius won the 2021 Nobel Prize in Physiology or Medicine for his work on pain sensation. “It was really a shock,” he says.
How neuroscientists harnessed the power of artificial intelligence to give a paralyzed man back his voice.
UCSF experts share their favorite science-based, judgment-free tips.
Since the early months of the pandemic, physicians throughout UCSF have pitched in to help support hundreds of long COVID patients.
A concerted research effort gave UCSF scientists early insight into long COVID. It also showed patients that they weren’t in the fight alone.
A student-run clinic that offers forensic medical evaluations helps asylum-seekers escape extreme violence and persecution.
For patients with skin cancer & facial sarcoma, reconstructing the face with skin grafted from the leg may result in poor color match. A new technique pioneered by UCSF surgeons uses pigmented tissue to achieve a better match.
Helen Diller Family Cancer Research Building Experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most
The UCSF initiative aims to increase the effectiveness and availability of chimeric antigen receptor T-cell (CAR T) therapy for lymphoma patients.